Amphastar Pharmaceutical (amph 2 03/15/29)
13F holders, Q3 2025 (September 30)10holders +2
2new positions
0sold out
$1.38avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding Amphastar Pharmaceutical (amph 2 03/15/29) in their 13F filings, up 2 from Q2 2025. 2 opened new positions and 0 sold out. The largest holders were Nomura Holdings Inc. ($610K), Truist Financial Corp. ($463K) and Bank of New York Mellon Corp ($273K).
- Company
- Amphastar Pharmaceutical (amph 2 03/15/29)
- CUSIP
- 03209RAB9
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $468K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 519,000 shares bought and 35,005 shares sold, net +483,995 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Nomura Holdings Inc. | 0.00% | Reduce -53.2% | 22,875 | $610K |
| Truist Financial Corp. | 0.00% | New | 511,000 | $463K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $273K |
| Sei Investments Co. | 0.00% | No change | 139,000 | $126K |
| Cetera Investment Advisers | 0.00% | Reduce -7.5% | 111,000 | $101K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +3.7% | 85,000 | $77K |
| Choreo, LLC | 0.00% | No change | 37,000 | $34K |
| Stephens Inc. | 0.00% | No change | 26,000 | $24K |
| Comerica Bank | 0.00% | No change | 11,000 | $10K |
| Fifth Third Bancorp | 0.00% | New | 5,000 | $5K |
"% of holder's portfolio" is AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29)'s weight in each manager's 13F, not the share of Amphastar Pharmaceutical (amph 2 03/15/29) the manager owns.